Frontlight ResearchEarly access
HIV trials in Hong Kong
1 of 5 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleHIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
- Where
- Shatin
- Age
- 18 years to 60 years
- People
- 22
- Run by
- Immuno Cure Holding (HK) Limited
See details and how to joinNCT07530198